Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 26:3:63.
doi: 10.3389/fonc.2013.00063. eCollection 2013.

Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy

Mark J Dobrzanski  1
Affiliations

Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy

Mark J Dobrzanski. Front Oncol. .

Abstract

The importance of CD4 T cells in orchestrating the immune system and their role in inducing effective T cell-mediated therapies for the treatment of patients with select established malignancies are undisputable. Through a complex and balanced array of direct and indirect mechanisms of cellular activation and regulation, this functionally diverse family of lymphocytes can potentially promote tumor eradication, long-term tumor immunity, and aid in establishing and/or rebalancing immune cell homeostasis through interaction with other immune cell populations within the highly dynamic tumor environment. However, recent studies have uncovered additional functions and roles for CD4 T cells, some of which are independent of other lymphocytes, that can not only influence and contribute to tumor immunity but paradoxically promote tumor growth and progression. Here, we review the recent advances in our understanding of the various CD4 T cell lineages and their signature cytokines in disease progression and/or regression. We discuss their direct and indirect mechanistic interplay among themselves and with other responding cells of the antitumor response, their potential roles and abilities for "plasticity" and memory cell generation within the hostile tumor environment, and their potentials in cancer treatment and immunotherapy.

Keywords: CD4 helper cells; T regulatory cells; cytokines; cytolytic CD4 T cells; immunotherapy; memory T cells; tumor immunity.

PubMed Disclaimer

References

    1. Acosta-Rodriguez E. V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. (2007). Surface phenotype and antigen specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8, 639–64610.1038/ni1467 - DOI - PubMed
    1. Agnello D., Lankford C. S., Bream J., Morinobu A., Gadina M., O’Shea J. J., et al. (2003). Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J. Clin. Immunol. 23, 147–16110.1023/A:1023381027062 - DOI - PubMed
    1. Aguirre-Ghiso J. A. (2007). Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 7, 834–84610.1038/nri2210 - DOI - PMC - PubMed
    1. Ahmed R., Gray D. (1996). Immunological memory and protective immunity: understanding their relation. Science 272, 54–6010.1126/science.272.5270.1904 - DOI - PubMed
    1. Alvaro T., Lejeune M., Salvadó M. T., Bosch R., García J. F., Jaén J., et al. (2005). Outcome in Hodgkin’s lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Cancer Res. 11, 1467–147310.1158/1078-0432.CCR-04-1869 - DOI - PubMed